Serum Fractalkine (CX3CL1) and Cardiovascular Outcomes and Diabetes: Findings From the Chronic Renal Insufficiency Cohort (CRIC) Study

Authors:
Publisher website
Google Scholar
Abstract
No abstract available
Funding Information
  • National Institutes of Health (R01-DK071224, R01-DK090505, K23-DK095913, K24-DK002651)
  • National Heart, Lung and Blood Institute of the NIH (R01-HL107196, K24-HL107643, U01-HL108636, R01-HL113147, U01DK061028)
  • NIDDK (U01DK060990, U01DK060984, U01DK061022, U01DK061021, U01DK060980, U01DK060963, U01DK060902)
  • NIH/National Center for Advancing Translational Sciences (NCATS) (UL1TR000003)
  • Johns Hopkins University (UL1 TR-000424)
  • University of Maryland (GCRC M01 RR-16500)
  • Clinical and Translational Science Collaborative of Cleveland
  • NCATS component of the NIH and NIH Roadmap for Medical Research (UL1TR000439)
  • Michigan Institute for Clinical and Health Research (MICHR) (UL1TR000433)
  • University of Illinois at Chicago (CTSA UL1RR029879)
  • Tulane University Translational Research in Hypertension and Renal Biology (P30GM103337)
  • Kaiser Permanente NIH/National Center for Research Resources (UCSF-CTSI UL1 RR-024131)

This publication has 33 references indexed in Scilit: